Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alseres Pharmaceuticals Inc (ALSE)
OTHER OTC:ALSE
Alseres Pharmaceuticals (ALSE) Financial Statements
6 Followers
Alseres Pharmaceuticals Financial Overview
| Jun 14 | Mar 14 | Dec 13 | Sep 13 | Jun 13 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 18.43K | $ 18.43K | $ 418.43K | $ 18.43K | $ 18.43K |
| Gross Profit | $ 18.43K | $ 18.43K | $ 418.43K | $ 18.43K | $ 18.43K |
| EBIT | $ -317.12K | $ -330.65K | $ 583.34K | $ -296.46K | $ -408.81K |
| EBITDA | $ -317.12K | $ -330.65K | $ 583.34K | $ -296.46K | $ -408.81K |
| Net Income Common Stockholders | $ -321.00K | $ -332.01K | $ 239.04K | $ -362.67K | $ -520.05K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 194.35K | $ 278.42K | $ 320.96K | $ 51.50K | $ 53.86K |
| Total Assets | $ 279.02K | $ 364.43K | $ 385.47K | $ 136.87K | $ 147.89K |
| Total Debt | $ 8.42M | $ 8.13M | $ 7.82M | $ 6.68M | $ 6.46M |
| Net Debt | $ 8.22M | $ 7.85M | $ 7.50M | $ 6.63M | $ 6.41M |
| Total Liabilities | $ 11.66M | $ 11.38M | $ 11.05M | $ 27.78M | $ 27.42M |
| Stockholders Equity | $ -11.38M | $ -11.02M | $ -10.66M | $ -27.64M | $ -27.27M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -272.06K | $ -385.45K | $ -385.98K | $ -300.79K | $ -299.56K |
| Operating Cash Flow | $ -272.06K | $ -385.45K | $ -385.98K | $ -300.79K | $ -299.56K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 22.74K | $ 0.00 | $ 134.68K |
| Financing Cash Flow | $ 225.00K | $ 365.00K | $ 450.00K | $ 300.00K | $ 100.00K |
Alseres Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.